Escort Service Call Girls In Sarita Vihar,, 99530Β°56974 Delhi NCR
Β
Prostate cancer health talk
1. DR EZENWA E V.
MBBS, FMCS, FWACS,
MPH
CONSULTANT
UROLOGIST UBTH
PROSTATE CANCER AWARENESS
2. What weβll be talking about
ο What is prostate /prostate cancer?
ο How common is prostate cancer?
ο What causes it?
ο How does it manifest?
ο Tests to find prostate cancer early
ο Treatment for prostate cancer
ο Prevention of prostate cancer
ο Conclusion
3. What is prostate gland / prostate
cancer?
ο Prostate Gland:
- Found below the
bladder
and in front of the
rectum
-The size of a walnut or
golf ball
- Makes the fluid that is
part of semen
ο Prostate Cancer
- Malignant
transformation
of the cells of the
prostate
4. DISEASES OF THE PROSTATE
ο Prostatitis (infection and
inflammation)
ο Benign prostatic hyperplasia
/enlargement (BPH)
ο Carcinoma of the prostate
5. How common is prostate
cancer?
[1]Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394β424.
doi: 10.3322/caac.21492.
[2]Stephen Odunayo Ikuerowo et al. Prevalence and characteristics of prostate cancer among participants of a
community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination. Pan African
Medical Journal. 2013;15:129. [doi: 10.11604/pamj.2013.15.129.2489]
ο Worldwide: Second after lung cancer 1,276,106
new cases (2018) [1]
ο Occurs more often in African-American men.
ο Reasons - differences in social, environmental and
genetic factors
ο Nigeria - 1 in every 100 men (1046 per 100,000
men).[2]
ο Commonest cause of male cancer death in Nigeria
ο Rarely diagnosed in men younger than 40 years,
uncommon in men younger than 50 years.
ο Nigeria β late presentation
6.
7. What causes prostate cancer?
- RISK FACTORS
ο Age is the strongest risk factor
- 63% of prostate cancer occurs in men over the
age of 65.
ο Male sex - Testesterone
ο Race
- More common in African men than other men (X3)
ο Family history- (X2.5)
ο Genes
- Account for about 5-10% of prostate cancer
ο Others
- Diet β diaries, red meat, fatty food
8.
9. HOW DOES IT MANIFEST?
ο NO SYMPTOMS β following screening.
ο WITH SYMPTOMS β Difficulty with passing urine,
bloody
urine
ο WITH COMPLICATIONS
- low backache, weakness of the limb,
weight loss,
inability to pass urine, kidney failure,
low blood
level, chest pain, cough, yellowness
of
12. Tests to find prostate cancer early
ο PSA (prostate-specific antigen)
PSA is a protein produced by
cells of the prostate gland.
PSA test measures the level of
PSA in the blood.
Normal level: (0-4ng/ml)
ο PCA3 ( Urine)
ο DRE (digital rectal exam)
Doctor feels the surface of
the prostate gland for bumps,
hard spots, and any other
abnormalities
ο Prostate biopsy
13.
14. PSA AND PROSTATE CANCER
[*]Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al.
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0
ng per milliliter. N Engl J Med. 2004 May 27. 350 (22):2239-46
ο No PSA level guarantees the absence of prostate
cancer.
ο The risk of disease increases as the PSA level
increases, from about
- 8% with PSA levels of β€1.0 ng/mL [*]
- 25% with PSA levels of 4-10 ng/mL
- 50% for levels over 10 ng/mL [1]
15. What can increase the PSA
level?
ο Prostate cancer
ο BPH (benign prostatic hyperplasia)
- Enlargement of the prostate gland (not cancer)
ο Age
- PSA level tends to go up with age
ο Prostatitis
- Infection/inflammation on the prostate gland
ο Ejaculation
- Increases PSA levels for a short time
- Men are asked to abstain from ejaculation for 2
days before
testing
Clearly, factors other than prostate cancer can
increase PSA level.
18. Screening Protocol :(ACS Screening
Guidelines)
ο Does not recommend routine screening in any
age group.
ο Asymptomatic men with at least a 10-year life
expectancy should be given an opportunity to
make an informed decision with their health care
provider after receiving information on the
uncertainties, risks and benefits of screening
ο Age 45 for those at high risk, including African
Americans and men with a first-degree relative
(father, brother, son) diagnosed with prostate
cancer before age 65
ο Age 40 for those at higher risk (more than one
first-degree relative diagnosed with prostate
19. Screening Protocol :(ACS Screening
Guidelines)
ο Men who decide to be screened should be tested with
- PSA test.
- A digital rectal exam (DRE)
ο If screening does not detect cancer, the time between
subsequent screenings depends on the results of the
blood test, as follows:
ο PSA < 2.5 ng/ml β Retesting may be done every 2
years
ο PSA β₯2.5 ng/ml β Retesting should be done annually
20. Treatment
ο Depends on:
- the stage / grade of the disease ( Risk assessment).
- age / life expectancy
ο Options
- Active surveillance
- Watchful waiting
- Surgery
- Radiotherapy
- Hormone ablation
- Chemotherapy
- Anti- androgens
- others β Cryotherapy, HIFU
21. Side Effects of Treatment
ο Erectile dysfunction
ο Low libido
ο Urinary incontinence
22. Can prostate cancer be
prevented
β’ Diets
- mainly of vegetables, fruits and fish. Tomatoes
(because of their lycopene content), green tea, and soy
have all been hypothesized to be beneficial.
- Avoid Obesity
- Low-fat diet
- Nutritional supplements also have not proved beneficial in
research studies eg Selenium and Vitamin E
- some protective effect with vitamin D
β’ Physical activity appears to lower prostate cancer risk.
23. Increased frequency of Ejaculation
reduces prostate cancer !!
ο Study Aim*: To asses if ejaculation
frequency throughout adulthood is related
to prostate cancer risk in a large US-based
study.
ο Outcome: Men reporting higher (21 times
per month) compared to lower ejaculatory
frequency ( 4 -7 times per month) in
adulthood were less likely to be
subsequently diagnosed with prostate
cancer.
ο *Jennifer R. Rider, Kathryn M. Wilson, Jennifer A. Sinnott, Rachel S. Kelly, Lorelei A. Muccia, Edward L.
Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-
up.
Eur Urol 2016;70:974β82
29. Controversy
[*] Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, et al. Radical
prostatectomy versus observation for localized prostate cancer. N Engl J
Med. 2012 Jul 19. 367(3):203-13
ο Among men with localized prostate cancer
detected during the early era of PSA testing,
radical prostatectomy did not significantly reduce
all-cause or prostate-cancer mortality, as
compared with observation, through at least 12
years of follow-up. Absolute differences were less
than 3 percentage points.[*]
30. Benefits of Early Detection
[*] Cost analyses of prostate cancer screening: frameworks for discussion. Investigators of
the American Cancer Society-National Prostate Cancer Detection Project. Littrup PJ,
Goodman AC, Mettlin CJ, Murphy GP.
J Urol. 1994 Nov;152(5 Pt 2):1873-7.
ο Early detection and potential for curative care
ο Poor outcome with advanced disease
ο More virulent disease among Africans
ο Avoidance of side effects of managing advanced
disease
ο Cost effective [*]
32. Conclusion
ο Prostate cancer is very common among
Nigerian men
ο It runs in families
ο Need for screening which should start at
the age of 40
ο Test for screening is available and safe
ο Treatment for cancer of the prostate
when diagnosed is available .
ο Healthy diet, physical exercise and
maintaining right weight are important